Paper19038618
Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.
Toris CB and 2 others. Surv Ophthalmol, 2008. Cited by 236 papers, by iCite.
Cite this record
ConductScience Library. Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Papers, record 19038618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19038618
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Glaucoma, Open-Angle | Major topic |
| Intraocular Pressure | Major topic |
| Prostaglandins F, Synthetic | Major topic |
| Administration, Topical | |
| Animals | |
| Aqueous Humor | |
| Humans | |
| Ocular Hypertension |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 EY016665 | NEI NIH HHS | United States | P30EY016665 | PubMed and NIH | NIH RePORTER |
| R01 EY002698 | NEI NIH HHS | United States | R01EY002698 | PubMed and NIH | NIH RePORTER |
| EY002698 | NEI NIH HHS | United States | R01EY002698 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07074782 | Retinal Ganglion Cell Neuroprotection Under Prostaglandin Analogues | Background |
Source ClinicalTrials.gov
References89
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16109646 | Prostaglandins E1 and E2, but not F2alpha or latanoprost, inhibit monkey ciliary muscle contraction. | Curr Eye Res | 2005 | https://conductscience.org/library/papers/16109646 | PubMed |
| 2 | 4066210 | Effect of intraocular pressure on uveoscleral outflow following cyclodialysis in the monkey eye. | Invest Ophthalmol Vis Sci | 1985 | https://conductscience.org/library/papers/4066210 | PubMed |
| 3 | 16936121 | The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey. | Invest Ophthalmol Vis Sci | 2006 | https://conductscience.org/library/papers/16936121 | PubMed |
| 4 | 2086407 | [Electron microscopy and immunohistochemical studies of the intraocular pressure lowering effect of prostaglandin F2 alpha]. | Fortschr Ophthalmol | 1990 | https://conductscience.org/library/papers/2086407 | PubMed |
| 5 | 17473728 | Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure. | J Glaucoma | 2007 | https://conductscience.org/library/papers/17473728 | PubMed |
| 6 | 14733708 | Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. | J Ocul Pharmacol Ther | 2003 | https://conductscience.org/library/papers/14733708 | PubMed |
| 7 | 12454040 | Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells. | Invest Ophthalmol Vis Sci | 2002 | https://conductscience.org/library/papers/12454040 | PubMed |
| 8 | 10509658 | Flow after prostaglandin E1 is mediated by receptor-coupled adenylyl cyclase in human anterior segments. | Invest Ophthalmol Vis Sci | 1999 | https://conductscience.org/library/papers/10509658 | PubMed |
| 9 | 14583136 | Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation. | J Ocul Pharmacol Ther | 2003 | https://conductscience.org/library/papers/14583136 | PubMed |
| 10 | 17444800 | A modified in vitro method for aqueous humor outflow studies in enucleated porcine eyes. | J Ocul Pharmacol Ther | 2007 | https://conductscience.org/library/papers/17444800 | PubMed |
| 11 | 11797317 | Enhancement of scleral macromolecular permeability with prostaglandins. | Trans Am Ophthalmol Soc | 2001 | https://conductscience.org/library/papers/11797317 | PubMed |
| 12 | 3190548 | Ultrastructural evidence for lymphatic capillaries in the primate choroid. | Arch Ophthalmol | 1988 | https://conductscience.org/library/papers/3190548 | PubMed |
| 13 | 16505029 | Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost. | Invest Ophthalmol Vis Sci | 2006 | https://conductscience.org/library/papers/16505029 | PubMed |
| 14 | 12623831 | Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. | Ophthalmology | 2003 | https://conductscience.org/library/papers/12623831 | PubMed |
| 15 | 10369592 | Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. | Arch Ophthalmol | 1999 | https://conductscience.org/library/papers/10369592 | PubMed |
| 16 | 15557445 | Prostaglandin FP agonists alter metalloproteinase gene expression in sclera. | Invest Ophthalmol Vis Sci | 2004 | https://conductscience.org/library/papers/15557445 | PubMed |
| 17 | 6581147 | Prostaglandin production by human trabecular cells: in vitro inhibition by dexamethasone. | Invest Ophthalmol Vis Sci | 1983 | https://conductscience.org/library/papers/6581147 | PubMed |
| 18 | 11726622 | Mechanisms of action of unoprostone on trabecular meshwork contractility. | Invest Ophthalmol Vis Sci | 2001 | https://conductscience.org/library/papers/11726622 | PubMed |
| 19 | 15650608 | Effects of travoprost on aqueous humor dynamics in monkeys. | J Glaucoma | 2005 | https://conductscience.org/library/papers/15650608 | PubMed |
| 20 | 9154279 | Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. | Surv Ophthalmol | 1997 | https://conductscience.org/library/papers/9154279 | PubMed |
Cited by136
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 236 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42653864 | Latanoprost Acid-Brimonidine, a New Amide Prodrug for Glaucoma Management Based on the Concept of Sustained Release. | Molecules | 2026 | https://conductscience.org/library/papers/42653864 | PubMed |
| 42631779 | Global landscape and thematic evolution of glaucoma pharmacotherapy research (1996-2025): A bibliometric and science mapping analysis. | Int Ophthalmol | 2026 | https://conductscience.org/library/papers/42631779 | PubMed |
| 42396508 | Transcriptomic Atlas of Human Trabecular Meshwork Uncovers the Cellular Landscape and Provides Insights into Glaucoma Pathophysiology. | Res Sq | 2026 | https://conductscience.org/library/papers/42396508 | PubMed |
| 42232614 | A Comprehensive Review of the Clinical Evidence Comparing Benzalkonium Chloride-Preserved and Benzalkonium Chloride-Free Latanoprost in the Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension. | Clin Ophthalmol | 2026 | https://conductscience.org/library/papers/42232614 | PubMed |
| 42154749 | Evolution of intraocular pressure after cataract surgery in nonglaucomatous patients: A post-hoc analysis of PERCEPOLIS clinical trial data. | PLoS One | 2026 | https://conductscience.org/library/papers/42154749 | PubMed |
| 41734022 | Lipidomic analysis reveals drug-induced lipoxin synthesis in glaucoma treatment. | JCI Insight | 2026 | https://conductscience.org/library/papers/41734022 | PubMed |
| 41240260 | Evaluation of corneal epithelial thickness by anterior segment optical coherence tomography in glaucoma patients receiving topical prostaglandin and dry eye treatment. | Int Ophthalmol | 2025 | https://conductscience.org/library/papers/41240260 | PubMed |
| 41047758 | Effects of Omidenepag Isopropyl Versus Latanoprost Eye Drops on Intraocular Pressure, Pupil Diameter, and Anterior Chamber Parameters in Normal Feline Eyes: A Pilot Study. | Vet Ophthalmol | 2026 | https://conductscience.org/library/papers/41047758 | PubMed |
| 40861241 | Efficacy and safety of prostaglandin drugs for elevated intraocular pressure: a Bayesian network meta-analysis. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40861241 | PubMed |
| 40570009 | Increased sensitivity of primary aniridia limbal stromal cells to travoprost, leading to elevated migration and MMP-9 protein levels, in vitro. | PLoS One | 2025 | https://conductscience.org/library/papers/40570009 | PubMed |
| 40224211 | Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review. | Front Ophthalmol (Lausanne) | 2025 | https://conductscience.org/library/papers/40224211 | PubMed |
| 40149925 | Effects of Brimonidine, Latanoprost, and Omidenepag on Tunicamycin-Induced Endoplasmic Reticulum Stress and Fibrosis in Human Trabecular Meshwork Cells. | Biomolecules | 2025 | https://conductscience.org/library/papers/40149925 | PubMed |
| 39951397 | Adult male-specific inverse association between dry eye disease and intraocular pressure: KNHANES 2010-2012. | PLoS One | 2025 | https://conductscience.org/library/papers/39951397 | PubMed |
| 39902753 | Development of a conjunctival contact-type drug delivery device for latanoprost using hyaluronic acid. | Drug Deliv | 2025 | https://conductscience.org/library/papers/39902753 | PubMed |
| 39867351 | Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study. | Clin Ophthalmol | 2025 | https://conductscience.org/library/papers/39867351 | PubMed |
| 39769228 | Association of Matrix Metalloproteinases Polymorphisms with Glaucoma Risk, Glaucoma Phenotype, and Response to Treatment with Selective Laser Trabeculoplasty or Latanoprost. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769228 | PubMed |
| 39458903 | Roles of Prostaglandins and Hydrogen Sulfide in an Outflow Model of the Porcine Ocular Anterior Segment Ex Vivo. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39458903 | PubMed |
| 39328825 | Subconjunctival Administration of an Adeno-Associated Virus Expressing Stanniocalcin-1 Provides Sustained Intraocular Pressure Reduction in Mice. | Ophthalmol Sci | 2025 | https://conductscience.org/library/papers/39328825 | PubMed |
| 39051019 | Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial. | Clin Ophthalmol | 2024 | https://conductscience.org/library/papers/39051019 | PubMed |
| 38642251 | Development of Cell Culture Platforms for Study of Trabecular Meshwork Cells and Glaucoma Development. | Tissue Eng Regen Med | 2024 | https://conductscience.org/library/papers/38642251 | PubMed |
Genes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19038618
GET https://conductscience.org/api/papers/v1/19038618/references?page=2